Effects of the Anti-CD20 Antibody Rituximab on B Cells in Human Secondary Lymphoid Organs

被引：0
|
作者：
Kamburova, E. [1 ]
Borgman, K. [1 ]
Hans, K. [1 ]
ten Berge, I [2 ]
Joosten, I [1 ]
Hilbrands, L. [3 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Lab Med, Lab Med Immunol, Nijmegen, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Nephrol, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nephrol, Nijmegen, Netherlands
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00310
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
929
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [21] Effects of combined therapy with gemcitabine and the anti-CD20 monoclonal antibody rituximab on human lymphoma cell lines.
    Joshi, I
    Jin, F
    Obasaju, C
    Smith, MR
    BLOOD, 2002, 100 (11) : 308B - 308B
  • [22] Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
    Cooper, HL
    Healy, E
    Theaker, JM
    Friedmann, PS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (04) : 366 - 368
  • [23] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
  • [24] The anti-CD20 antibody Rituximab reduces the Th17 response
    van de Veerdonk, Frank L.
    Lauwerys, Bernard
    DiPadova, Franco
    Marijnissen, Renoud J.
    Koenders, Marije I.
    Gutierrez-Roelens, Ilse
    Durez, Patrick
    Netea, Mihai G.
    van der Meer, Jos W. M.
    van den Berg, Wim B.
    Joosten, Leo A. B.
    CYTOKINE, 2009, 48 (1-2) : 98 - 98
  • [25] Anti-cd20 monoclonal antibody treatment (rituximab) in acute lymphoblastic leukemia
    Jándula, BM
    Nomdedeu, J
    Marín, P
    Muñoz, L
    Vivancos, P
    BONE MARROW TRANSPLANTATION, 2001, 27 : S92 - S92
  • [26] Rituximab (anti-CD20 monoclonal antibody) - Ultimate or first choice in pemphigus?
    Hertl, Michael
    Eming, Ruediger
    Borradori, Luca
    DERMATOLOGY, 2007, 214 (04) : 275 - 277
  • [27] An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
    Boye, J
    Elter, T
    Engert, A
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 520 - 535
  • [28] Anti-CD20 (rituximab) in follicular lymphoma
    McLaughlin, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [29] Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
    Dupuy, A
    Viguier, M
    Bédane, C
    Cordoliani, F
    Blaise, S
    Aucouturier, F
    Bonnetblanc, JM
    Morel, P
    Dubertret, L
    Bachelez, H
    ARCHIVES OF DERMATOLOGY, 2004, 140 (01) : 91 - 96
  • [30] Structural Characterization of the Full-Length Anti-CD20 Antibody Rituximab
    Belviso, Benny Danilo
    Mangiatordi, Giuseppe Felice
    Alberga, Domenico
    Mangini, Vincenzo
    Carrozzini, Benedetta
    Caliandro, Rocco
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
12345